Cos Cob, CT, United States of America

Kieran Curley

USPTO Granted Patents = 3 


Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2018-2021

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: The Innovations of Kieran Curley: A Pioneer in Pharmaceutical Composition

Introduction

Kieran Curley, an accomplished inventor based in Cos Cob, Connecticut, has made significant strides in the field of pharmaceutical innovations. With a total of three patents to his name, Curley specializes in developing heat-stable dry powder pharmaceutical compositions that promise enhanced stability and usability in various environments.

Latest Patents

Curley's latest patent focuses on the creation of heat-stable dry powders comprising peptides or proteins, including oxytocin. These pharmaceutical compositions are designed to maintain high stability even under increased temperatures and humid conditions. The formulations are intended for storage at room temperature, boasting an improved shelf-life, and are primarily intended for inhalation. However, they can also be reconstituted for alternative routes of administration.

Career Highlights

Kieran Curley is currently affiliated with MannKind Corporation, a prominent player in the biotech sector. His work revolves around innovative pharmaceutical solutions that cater to the growing demands of modern medical therapies. Curley's contributions have positioned him as a key inventor in the realm of drug formulation, emphasizing the importance of stability and efficacy in pharmaceutical products.

Collaborations

Throughout his career, Curley has collaborated with notable colleagues, including Karine Fabio and Joseph J Guarneri. Their teamwork exemplifies a commitment to advancing pharmaceutical research and developing next-generation treatments that can withstand diverse environmental challenges.

Conclusion

Kieran Curley's innovative approach to heat-stable dry powder pharmaceutical compositions has the potential to revolutionize drug delivery systems. His work not only addresses critical storage challenges but also enhances patient accessibility to essential medications. With a strong foundation at MannKind Corporation and a network of collaborative efforts, Curley's inventions hold promise for the future of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…